Sonic Healthcare (OTCMKTS:SKHHY) Stock Rating Raised to Hold at Zacks Research

Zacks Research upgraded shares of Sonic Healthcare (OTCMKTS:SKHHY) from a strong sell rating to a hold rating in a research report released on Monday morning,Zacks reports.

Separately, The Goldman Sachs Group downgraded Sonic Healthcare from a “buy” rating to a “hold” rating in a report on Sunday, October 11th. Two analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Reduce”.

Sonic Healthcare Trading Up 1.9%

Shares of SKHHY stock opened at $13.08 on Monday. Sonic Healthcare has a fifty-two week low of $12.58 and a fifty-two week high of $17.49. The business’s 50 day moving average price is $13.87 and its 200-day moving average price is $14.15.

Sonic Healthcare Company Profile

Sonic Healthcare Limited is an Australian healthcare company specializing in medical diagnostics. Its principal business is laboratory medicine, providing pathology and clinical testing services used to diagnose, monitor and manage a broad range of medical conditions. The company serves hospitals, physicians, healthcare organizations and patients through networks of medical laboratories and collection centers.

Sonic Healthcare also operates medical imaging businesses in selected markets and provides related healthcare services, including occupational health and primary care offerings in Australia.